98%
921
2 minutes
20
Background: As overdose rates increase for multiple substances, policymakers need to identify geographic patterns of substance-specific deaths. In this study, we describe county-level opioid and psychostimulant overdose patterns and how they correlate with county-level social vulnerability measures.
Methods: A cross-sectional observational study, we used nationwide 2016-2018 restricted access Centers for Disease Prevention and Control county-level mortality files for 1,024 counties. We estimated quartiles of opioid and psychostimulant overdose mortality and provided estimates of their association with county-level Social Vulnerability Index (SVI) percentile.
Results: There was high opioid and psychostimulant overdose mortality in the Middle Atlantic, South Atlantic, East North Central, and Mountain regions. The Central US had the lowest opioid and psychostimulant overdose mortality rates. Counties with higher SVI scores (i.e. higher social vulnerability) were significantly more likely to experience high opioid and high psychostimulant overdose (high-high) mortality. A 10-percentile increase in SVI score was associated with a 3.1 percentage point increase in the likelihood of being a high-high county (p < 0.001) in unadjusted models and a 1.5 percentage point increase (p < 0.05) in models adjusting for region.
Conclusion: Our results illustrated the heterogenous geographic distribution of the growing concurrent opioid and psychostimulant overdose crisis. The substantial regional variation we identified highlights the need for local data to guide policymaking and treatment planning. The association of opioid-psychostimulant overdose mortality with social vulnerability demonstrates the critical need in impacted counties for tailored treatment that addresses the complex medical and social needs of people who use both opioids and psychostimulants.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923074 | PMC |
http://dx.doi.org/10.1080/10826084.2023.2287220 | DOI Listing |
Exp Clin Psychopharmacol
September 2025
Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine.
Nearly 2 million people had a diagnosis of methamphetamine use disorder (MUD) in 2023 and overdose deaths involving psychostimulants are increasing. Given that there are no currently approved U.S.
View Article and Find Full Text PDFMMWR Morb Mortal Wkly Rep
August 2025
Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC.
Drug overdose deaths involving stimulants have increased in the United States since 2011. This report describes characteristics of stimulant-involved overdose deaths during January 2021-June 2024 using CDC's State Unintentional Drug Overdose Reporting System data and trends by drug and race and ethnicity during 2018-2023 using CDC's National Vital Statistics System data. Overall, 59.
View Article and Find Full Text PDFJ Subst Use Addict Treat
August 2025
Department of Pharmaceutical Outcomes & Policy, University of Florida, Gainesville, FL, USA; Center for Drug Evaluation and Safety, University of Florida, Gainesville, FL, USA; Department of Information Systems and Operations Management, University of Florida, Gainesville, FL, USA. Electronic addres
Importance: Attention-deficit/hyperactivity disorder (ADHD) is a condition often comorbid with substance use disorders. With the increase in opioid and stimulant overdoses, there remains concern regarding the appropriateness of psychostimulants for patients on maintenance therapy for opioid use disorder (OUD) with co-occurring ADHD.
Objectives: To assess the impact of psychostimulant use on outcomes of OUD maintenance therapy with buprenorphine based on rates of (1) treatment discontinuation and (2) opioid-related hospitalization.
Inj Epidemiol
August 2025
Department of Biostatistics, College of Public Health, University of Kentucky, 260 Healthy Kentucky Research Bldg, Lexington, KY, 40536, USA.
Background: Kentucky has historically experienced a high burden of drug overdose deaths. During the first years of the COVID-19 pandemic, the state saw a 45% increase in overdose deaths in 2020, followed by an additional 15% increase in 2021. However, drug overdose deaths declined in 2023 and 2024.
View Article and Find Full Text PDFAddict Behav
August 2025
Johns Hopkins Bloomberg School of Public Health, Center for Indigenous Health, United States.
We describe stages of opioid and psychostimulant use (i.e., onset of use and progression to dependence) over the early life course within Indigenous communities where drug overdose impacts have been most extreme.
View Article and Find Full Text PDF